Interventional Oncology Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2032 | Siemens Healthineers AG (Varian) (US),Medtronic

Global Interventional Oncology Market Size, Status, and forecast for the 2025-2032. The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Interventional Oncology Market industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Additionally, the report includes upstream and downstream analyses of key players, as well as global certainties and assurances. The report evaluates dynamic aspects such as forecast market information, Porter's Five Forces Analysis, sales estimates, wide product portfolio, market scenarios, and possibility studies.

The global interventional oncology market, valued at US$2.54 billion in 2023, is forecasted to grow at a robust CAGR of 9.1%, reaching US$2.76 billion in 2024 and an impressive US$4.25 billion by 2032.

Updated Version of Sample Report Included:
https://www.marketdigits.com/request/sample/4176

Interventional Oncology Market Dynamics

Market Driver:

Expansion in the patient population for cancer is an important growth driver in the interventional oncology market. In fact, due to multiple causes, including age, lifestyle factors, and increasing exposure to risk factors from environmental sources, the global incidence of cancer has increased steadily over time. The most common forms of cancers are those affecting the liver, lung, kidney, and colorectal regions; most of the cases are diagnosed at advance stages wherein conventional surgical interventions are either ineffective or cannot be applied. This increasing patient population is demanding more of minimally invasive, image-guided interventions by interventional oncologists, in providing potential palliative and curative options.

Market Restraint:

The expensive equipment involved with such procedures as well as sophisticated tools form some of the essential limitations holding the growth of interventional oncology. In particular, some treatments involving the disease under this treatment procedure are more sophisticated; thus, for TACE, TARE, and percutaneous ablation, for example, involve Yttrium-90 and a wide array of specialized catheters and embolic agents coupled with imaging technology in top shape, adding greatly to its expensive costs due to production and upscaling and other means.In addition, the highly specialized interventional radiologists and auxiliary staff increase the costs of the procedure.

Major Players in Interventional Oncology Markets are:

Siemens Healthineers AG (Varian) (US),Medtronic (Ireland),Boston Scientific Corporation (US),Terumo Corporation (Japan),Merit Medical Systems (US),Johnson & Johnson MedTech ( Ethicon) (US),Stryker (US),Teleflex Incorporated (US),AngioDynamics (US),Cook (US),IceCure Medical (Israel),Olympus Corporation (Japan),IMBiotechnologies Ltd (Canada),MedWaves Inc. (US),Minimax Medical Limited (China),ABK Biomedical Inc. (Canada),RF Medical Co., Ltd. (South Korea),Profound Medical (Canada),Surgnova (China),STARmed America (US)

Industry News:

In December 2024, AngioDynamics, Inc, expanding cancer treatment options and improving patient quality of life, announced receiving U.S. Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife System for prostate tissue ablation.

In December 2024, Siemens Healthineers and AP-HP signed a partnership to innovate healthcare. This agreement strengthens their collaboration in medical imaging, diagnostics, and advanced therapies to improve patient care and adapt to changes in the French healthcare system, aiming to co-develop new.

In November 2024, Boston announced entering into a definitive agreement to acquire Intera Oncology Inc., a privately held medical device company that provides the Intera 3000 Hepatic Artery Infusion Pump and floxuridine, a chemotherapy drug, both of which are approved by the U.S. Food and Drug Administration.

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Global Interventional Oncology Market Segmentation:

Interventional Oncology Market By Type
Radiation Therapy Devices
Ablation Devices
o Microwave ablation
o Radiofrequency ablation
o Cryoablation
o Others
Embolization Devices
o Microcatheters
o Guidewires

Interventional Oncology Market By Cancer Type
Lung Cancer
Liver Cancer
Kidney Cancer
Others

Interventional Oncology Market By End-User
Hospitals
Specialty Clinics
Others

Know more about this report:
https://www.marketdigits.com/interventional-oncology-market-1708503695

The following areas and countries are covered in the worldwide Interventional Oncology Market file:

North America (US, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE), Egypt, Nigeria, and South Korea)

The interventional oncology market is dominated by North America due to the well-developed health care infrastructure in the region, widespread acceptance of advanced medical technologies, and rising cancer cases. The United States is the biggest market within this region due to the existence of a well-established network of cancer centers and hospitals with modern facilities for interventional radiology. The growing incidence of liver, lung, and kidney cancers-the main areas for interventional oncology-provides significant impetus for less invasive treatments such as TACE, TARE, and thermal ablation. That the healthcare sector will be augmented by interventions in the form of highly qualified professionals, such as interventional radiologists and oncologists, also adds to the growth momentum.

Detailed industry forecast-Brief Introduction to the research report:

Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Discover More: Visit Our Website for Additional Reports!

https://www.marketdigits.com/flexible-substrates-market-1694773799

https://www.marketdigits.com/adhesion-promoter-market-1694773799

https://www.marketdigits.com/sodium-sulfur-batteries-market-1694773799

https://www.marketdigits.com/polymethacrylimide-foam-market-1694773799

https://www.marketdigits.com/plastic-fillers-market-1694773799

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.